Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Volume 24, 2021 - Issue 5
711
Views
6
CrossRef citations to date
0
Altmetric
Articles

Calorie restriction in combination with prebiotic supplementation in obese women with depression: effects on metabolic and clinical response

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • World Health Organization. Depression and other common mental disorders global health estimates 2017. http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf [2018/06/01].
  • Luppino FS, de Wit LM, Bouvy PF, Stijnen T, Cuijpers P, Penninx BW, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Archives Gen Psychiatry. 2010;67(3):220–9.
  • Penninx BW, Milaneschi Y, Lamers F, Vogelzangs N. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med. 2013;11:129.
  • Ra JS, Kim HS. Sex-based association between depression and metabolic syndrome in Korean middle-aged and older adults. Osong Public Health Res Perspect. 2017;8(2):130–7.
  • Pereira-Miranda E, Costa PRF, Queiroz VAO, Pereira-Santos M, Santana MLP. Overweight and obesity associated with higher depression prevalence in adults: a systematic review and meta-analysis. J Am Coll Nutr. 2017;36(3):223–33.
  • Ha H, Han C, Kim B. Can obesity cause depression? A pseudo-panel analysis. J Prev Med Public Health. 2017;50(4):262–7.
  • Jensen-Otsu E, Austin GL. Antidepressant use is associated with increased energy intake and similar levels of physical activity. Nutrients. 2015;7(11):9662–71.
  • Lee SH, Paz-Filho G, Mastronardi C, Licinio J, Wong ML. Is increased antidepressant exposure a contributory factor to the obesity pandemic? Transl Psychiatry. 2016;6:e759.
  • Ouakinin SRS, Barreira DP, Gois CJ. Depression and obesity: integrating the role of stress, neuroendocrine dysfunction and inflammatory pathways. Front Endocrinol (Lausanne). 2018;9431.
  • Slyepchenko A, Maes M, Machado-Vieira R, Anderson G, Solmi M, Sanz Y, et al. Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes. Curr Pharm Des. 2016;22(40):6087–106.
  • Jakobsen JC, Katakam KK, Schou A, Hellmuth SG, Stallknecht SE, Leth-Moller K, et al. Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and trial sequential analysis. BMC Psychiatry. 2017;17(1):58.
  • Barnes ER, Theeke L, Minchau E, Mallow J, Lucke-Wold N, Wampler J. Relationships between obesity management and depression management in a university-based family medicine center. J Am Assoc Nurse Pract. 2015;27(5):256–61.
  • Koliaki C, Spinos T, Spinou M, Brinia Mu E, Mitsopoulou D, Katsilambros N. Defining the optimal dietary approach for safe, effective and sustainable weight loss in overweight and obese adults. Healthcare (Basel). 2018;6(3). pii: E73.
  • Redman LM, Ravussin E. Caloric restriction in humans: impact on physiological, psychological, and behavioral outcomes. Antioxid Redox Signal. 2011;14(2):275–87.
  • Zhang Y, Liu C, Zhao Y, Zhang X, Li B, Cui R. The effects of calorie restriction in depression and potential mechanisms. Curr Neuropharmacol. 2015;13(4):536–42.
  • Fitzgerald KC, Vizthum D, Henry-Barron B, Schweitzer A, Cassard SD, Kossoff E, et al. Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis. Mult Scler Relat Disord. 2018;23:33–9.
  • Pearl RL, Wadden TA, Tronieri JS, Berkowitz RI, Chao AM, Alamuddin N, et al. Short- and long-term changes in health-related quality of life with weight loss: results from a randomized controlled trial. Obesity. 2018;26(6):985–91.
  • Martin CK, Bhapkar M, Pittas AG, Pieper CF, Das SK, Williamson DA, et al. Effect of calorie restriction on mood, quality of life, sleep, and sexual function in healthy nonobese adults: The CALERIE 2 randomized clinical trial. JAMA Intern Med. 2016;176(6):743–52.
  • Redman LM, Martin CK, Williamson DA, Ravussin E. Effect of caloric restriction in non-obese humans on physiological, psychological and behavioral outcomes. Physiol Behav. 2008;94(5):643–8.
  • Gibson GR, Hutkins R, Sanders ME, Prescott SL, Reimer RA, Salminen SJ, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14:491.
  • Genta S, Cabrera W, Habib N, Pons J, Carillo IM, Grau A, et al. Yacon syrup: beneficial effects on obesity and insulin resistance in humans. Clin Nutr. 2009;28(2):182–7.
  • Dehghan P, Pourghassem Gargari B, Asgharijafarabadi M. Effects of high performance inulin supplementation on glycemic status and lipid profile in women with type 2 diabetes: a randomized, placebo-controlled clinical trial. Health Promot Perspect. 2013;3(1):55–63.
  • Pourghassem GB, Dehghan P, Aliasgharzadeh A, Asghari Jafar-Abadi M. Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes. Diabetes Metab J. 2013;37(2):140–8.
  • Abbasalizad FM, Javid AZ, Sarmadi B, Karimi P, Dehghan P. A randomized controlled trial on the efficacy of resistant dextrin, as functional food, in women with type 2 diabetes: targeting the hypothalamic–pituitary–adrenal axis and immune system. Clin Nutr. 2018;37(4):1216–23.
  • Committee IR 2005. Guidelines for data processing and analysis of the international physical activity questionnaire (IPAQ) – Short and long forms. Retrieved September 17 2008.
  • Sharp R. The Hamilton rating scale for depression. Occup Med. 2015;65(4):340.
  • Ghassemzadeh H, Mojtabai R, Karamghadiri N, Ebrahimkhani N. Psychometric properties of a Persian-language version of the Beck Depression Inventory–Second edition: BDI-II-PERSIAN. Depress Anxiety. 2005;21(4):185–92.
  • Ahmadpanah M, Sheikhbabaei M, Haghighi M, Roham F, Jahangard L, Akhondi A, et al. Validity and test-retest reliability of the Persian version of the Montgomery–Asberg Depression Rating Scale. Neuropsychiatr Dis Treat. 2016;12:603–7.
  • Ebrahimi A, Barekatain M, Bornamanesh A, Nassiri H. Psychometric properties of the Persian version of Bipolar Depression Rating Scale (BDRS) in Patients and General Population. IJPCP. 2015;21(1):60–8.
  • Ireton-Jones C. Intake: energy. In: JL MLaR, editor. Krause’s food and the nutrition care process. 14th ed. Louis, Missouri: Elsevier Inc.; 2017. p. 20–5.
  • Bonnema AL, Kolberg LW, Thomas W, Slavin JL. Gastrointestinal tolerance of chicory inulin products. J Am Diet Assoc. 2010;110(6):865–8.
  • Meyer D, Stasse-Wolthuis M. The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr. 2009;63(11):1277–89.
  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
  • Masson SC, Tejani AM. Minimum clinically important differences identified for commonly used depression rating scales. J Clin Epidemiol. 2013;66(7):805–7.
  • Inserra A, Rogers GB, Licinio J, Wong M-L. The microbiota-inflammasome hypothesis of major depression. BioEssays. 2018;40(9):1800027.
  • Frei R, Akdis M, O'Mahony L. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol. 2015;31(2):153–8.
  • Calabrese F, Rossetti AC, Racagni G, Gass P, Riva MA, Molteni R. Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity. Front Cell Neurosci. 2014;8(430).
  • Silverman MN, Sternberg EM. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann N Y Acad Sci. 2012;1261:55–63.
  • Ng QX, Peters C, Ho CYX, Lim Donovan Y, Yeo W-S. A meta-analysis of the use of probiotics to alleviate depressive symptoms. J Affect Disord. 2018;228:13–9.
  • Kazemi A, Noorbala AA, Azam K, Eskandari MH, Djafarian K. Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin Nutr. 2019;38(2):522–8.
  • Carlson JL, Erickson JM, Lloyd BB, Slavin JL. Health effects and sources of prebiotic dietary fiber. Curr Dev Nutr. 2018;2(3). nzy005.
  • John GK, Wang L, Nanavati J, Twose C, Singh R, Mullin G. Dietary alteration of the gut microbiome and its impact on weight and fat mass: a systematic review and meta-analysis. Genes (Basel). 2018;9(3).
  • Abrams SA, Griffin IJ, Hawthorne KM, Ellis KJ. Effect of prebiotic supplementation and calcium intake on body mass index. J Pediatr. 2007;151(3):293–8.
  • Dewulf EM, Cani PD, Claus SP, Fuentes S, Puylaert PGB, Neyrinck AM, et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut. 2013;62(8):1112–21.
  • Parnell JA, Reimer RA. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr. 2009;89(6):1751–9.
  • Delzenne NM, Neyrinck AM, Cani PD. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact. 2011;10(Suppl 1).
  • Dewulf EM, Cani PD, Neyrinck AM, Possemiers S, Van Holle A, Muccioli GG, et al. Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARgamma-related adipogenesis in the white adipose tissue of high-fat diet-fed mice. J Nutr Biochem. 2011;22(8):712–22.
  • Kritchevsky S, Group f, Martin CK, Williamson DA, Ravussin E, Redman LM, et al. A 2-year randomized controlled trial of human Caloric restriction: feasibility and effects on predictors of health span and longevity. J Gerontol A Biol Sci Med Sci. 2015;70(9):1097–104.
  • Martin CK, Heilbronn LK, de Jonge L, DeLany JP, Volaufova J, Anton SD, et al. Effect of calorie restriction on resting metabolic rate and spontaneous physical activity. Obesity. 2007;15(12):2964–73.
  • Bahr SM, Weidemann BJ, Castro AN, Walsh JW, deLeon O, Burnett CML, et al. Risperidone-induced weight gain is mediated through shifts in the gut microbiome and suppression of energy expenditure. EBioMedicine. 2015;2(11):1725–34.
  • Skonieczna-Zydecka K, Loniewski I, Misera A, Stachowska E, Maciejewska D, Marlicz W, et al. Second-generation antipsychotics and metabolism alterations: a systematic review of the role of the gut microbiome. Psychopharmacology. 2018 [Online First Articles; ISSN: 0033-3158 (Print) 1432-2072 (Online)]. Available from: https://link.springer.com/journal/213/onlineFirst/page/9 doi:10.1007/s00213-018-5102-6.
  • Bonsu NKA, Johnson S. Effects of inulin fibre supplementation on serum glucose and lipid concentration in patients with type 2 diabetes. Diabetes Metab. 2012;21(3):80–6.
  • Rosner B, Sacks FM, Brown L, Willett WW. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69(1):30–42.
  • Causey JL, Feirtag JM, Gallaher DD, Tungland BC, Slavin JL. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutr Res. 2000;20(2):191–201.
  • Asztalos B, Lefevre M, Wong L, Foster TA, Tulley R, Windhauser M, et al. Differential response to low-fat diet between low and normal HDL-cholesterol subjects. J Lipid Res. 2000;41(3):321–8.
  • Fabricatore AN, Wadden TA, Higginbotham AJ, Faulconbridge LF, Nguyen AM, Heymsfield SB, et al. Intentional weight loss and changes in symptoms of depression: a systematic review and meta-analysis. Int J Obes. 2011;35(11):1363–76.
  • Chaitoff A, Swetlik C, Ituarte C, Pfoh E, Lee LL, Heinberg LJ, et al. Associations between unhealthy weight-loss strategies and depressive symptoms. Am J Prev Med. 2019;56(2):241–50.
  • Stefańska E, Wendołowicz A, Konarzewska B, Ostrowska L. The effectiveness of a weight loss diet in a group of overweight and obese women with recurrent depressive disorders. Prz Menopauzalny. 2016;15(2):69–75.
  • Ruusunen A, Voutilainen S, Karhunen L, Lehto SM, Tolmunen T, Keinanen-Kiukaanniemi S, et al. How does lifestyle intervention affect depressive symptoms? results from the Finnish diabetes prevention study. Diabet Med. 2012;29(7):e126–32.
  • Chaput JP, Arguin H, Gagnon C, Tremblay A. Increase in depression symptoms with weight loss: association with glucose homeostasis and thyroid function. Appl Physiol Nutr Metab. 2008;33(1):86–92.
  • Lasikiewicz N, Myrissa K, Hoyland A, Lawton CL. Psychological benefits of weight loss following behavioural and/or dietary weight loss interventions. A systematic research review. Appetite. 2014;72:123–37.
  • Mamtani M, Kulkarni H, Dyer TD, Almasy L, Mahaney MC, Duggirala R, et al. Waist circumference independently associates with the risk of insulin resistance and type 2 diabetes in Mexican American Families. PLOS One. 2013;8(3):e59153.
  • Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14–24.
  • Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr. 1992;56(2):320–8.
  • Romero-Moraleda B, Peinado Lozano AB, Morencos Martinez E, Lopez-Plaza B, Gomez Candela C, Calderon Montero FJ. Lipid profile response to weight loss program in overweight and obese patient is related with gender and age. Nutr Hosp. 2015;31(6):2455–64.
  • Chan DC, Watts GF, Ng TW, Yamashita S, Barrett PH. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome. Eur J Clin Invest. 2008;38(10):743–51.
  • Uher R, Perlis RH, Placentino A, Dernovšek MZ, Henigsberg N, Mors O, et al. Self-report and clinician-rated measures of depression severity: can one replace the other? Depress Anxiety. 2012;29(12):1043–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.